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Abstract
Purpose: Adaptive radiotherapy (ART) has potential to reduce toxicity and facilitate
safe dose escalation. Dose calculations with the planning CT deformed to cone
beam CT (CBCT) have shown promise for estimating the “dose of the day”. The pur-
pose of this study is to investigate the “dose of the day” calculation accuracy based
on CBCT and deformable image registration (DIR) for lung cancer radiotherapy.
Methods: A total of 12 lung cancer patients were identified, for which daily CBCT
imaging was performed for treatment positioning. A re‐planning CT (rCT) was
acquired after 20 Gy for all patients. A virtual CT (vCT) was created by deforming
initial planning CT (pCT) to the simulated CBCT that was generated from deforming
CBCT to rCT acquired on the same day. Treatment beams from the initial plan were
copied to the vCT and rCT for dose calculation. Dosimetric agreement between
vCT‐based and rCT‐based accumulated doses was evaluated using the Bland‐Altman
analysis.
Results: Mean differences in dose‐volume metrics between vCT and rCT were smal-
ler than 1.5%, and most discrepancies fell within the range of ± 5% for the target
volume, lung, esophagus, and heart. For spinal cord Dmax, a large mean difference of
−5.55% was observed, which was largely attributed to very limited CBCT image
quality (e.g., truncation artifacts).
Conclusion: This study demonstrated a reasonable agreement in dose‐volume met-
rics between dose accumulation based on vCT and rCT, with the exception for cases
with poor CBCT image quality. These findings suggest potential utility of vCT for
providing a reasonable estimate of the “dose of the day”, and thus facilitating the
process of ART for lung cancer.
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1 | INTRODUCTION
Radiotherapy is a widely used treatment option for unresectable
or inoperable non‐small cell lung cancer (NSCLC) patients.
Although significant progress has been made in radiotherapy for
lung cancer in recent decades, improving clinical outcomes for
NSCLC is still challenging.1 Dose escalation is one of the potential
strategies to improve outcomes, but it may increase normal tissues
toxicities,2,3 for example, pneumonitis, pulmonary fibrosis, and car-
diac injury, among others. A phase III randomized trial failed to
demonstrate a survival benefit to dose escalation,1 with specula-
tion that normal tissue toxicity may have increased deaths with
high‐dose RT.4 It has been proposed that as tumor shrinks during
the course of treatment, adaptive radiotherapy (ART) may be ben-
eficial in reducing normal tissue toxicities and may allow safe dose
escalation.5
While ART is often done with repeat planning CT (rCT), utiliz-
ing cone beam computed tomography (CBCT) for estimating the
“dose of the day” has been an attractive research topic since they
are readily available along the treatment course. However, direct use
of CBCT in dose calculation is limited by inferior image quality and
thus inaccurate Hounsfield units (HU).6,7 Methods to mitigate or
resolve this issue include image correction8–11 and image deforma-
tion.12–21 The former has shown promises, yet dose calculation inac-
curacy still varies by up to 5% in phantom 7and patient studies of
various sites.22–24 The latter approach, which creates deformed CT
images from the initial planning CT (pCT) to CBCT, has potential to
maintain anatomical information from CBCT while mapping accurate
HU information from the pCT. Previous studies have shown promis-
ing results for estimating the “dose of the day” based on deformed
CT images.15,17–19,25 Marchant et al.15 found that less than 0.5%
mean dose errors can be achieved with the deformed CT images for
lung cancer patients, when compared with pCT. Veiga et al.18 also
demonstrated that the dose difference between deformed CT and
rCT images for head and neck patients treated with intensity modu-
lated radiotherapy (IMRT) was generally less than 2%. Same group
also reported 3.4 ± 2.7 mm and 12 ± 12% average difference
between deformed CT and rCT for lung cancer patients receiving
passive scattering proton therapy.17 Cole et al.21 also found that the
dose distribution based on deformed CT matched closely the rCT
dose distribution in lung cancer patients receiving conformal external
beam radiotherapy. An open source deformation algorithm was used
in this study, which may not be practical for clinical adoption.
Adapting from the literature,18,19,21 our present study aimed to
explore dosimetric accuracy of the “dose of the day” calculated on
virtual CTs for lung patients receiving nine‐field IMRT treatment
using commercially available deformation image registration (DIR)
algorithm from a treatment planning system. A virtual CT (vCT) was
created by deforming the initial planning CT (pCT) to the simulated
CBCT that was generated from deforming CBCT to the repeat plan-
ning CT (rCT) acquired on the same day. And the accuracy of the
“dose of the day” calculation based on vCT images was evaluated by
comparing the accumulated dose based on vCT to that of rCT
acquired on the same day using Bland‐Altman analysis with dosimet-
ric parameters.
2 | MATERIALS AND METHODS
2.A | Patients and imaging
This study investigated twelve patients with stage III NSCLC receiv-
ing nine‐field IMRT with a prescription dose of 60 Gy delivered in
30 fractions. Each patient underwent an rCT scan after 10 fractions
as part of an ongoing clinical trial approved by the University of Cali-
fornia Davis institutional review board (NCT02308709). Daily CBCT
images were also performed for patient positioning and target local-
ization. All pCT and rCT images were acquired during patient’s free‐
breathing on a Philips 16 slice Brilliance Big Bore multi‐slice CT (Phi-
lips Medical Systems, Eindhoven, The Netherlands) with 120 kVp,
120 mA, and 2 mm slice thickness. Maximum intensity projection
(MIP) CT was created based on the 10‐phase 4D CT for ITV delin-
eation. The CBCT images were acquired on the kV x‐ray imaging
system on the two matching Elekta Synergy® linear accelerator sys-
tems (Elekta AB, Stockholm, Sweden). CBCT scanning parameters
include 120 kV, 40 mA tuber potential, 40 ms exposure time,
2.5 mm reconstructed slice thickness with 410 × 410 mm field of
view (FOV), except one case with 20 mA and 20 ms. Note that only
the CBCT images acquired on the same day with the rCT were used
in this study.
2.B | Virtual CT with deformable image registration
The Demons DIR algorithm of the Pinnacle3 treatment planning sys-
tem (research version 9.7, Philips Radiation Oncology Systems, Fitch-
burg, WI) was used in this study. This algorithm performs image
deformation through matching image intensity with the assumption
that pixels representing the same anatomical point on each image
have the same image intensity values.26 The rCT and its correspond-
ing CBCT were acquired on the same day, therefore, should have
similar external contour and internal anatomy. Nevertheless, they
may still present small organ deformation and volume variation, due
to respiratory motion, positioning deviations, etc. In order to mini-
mize such differences, a simulated CBCT image was first created by
deforming CBCT to rCT (The workflow is shown in Fig. 1). Then the
pCT was deformed to the simulated CBCT to create vCT images.
2.C | Treatment planning
The initial treatment plan based on pCT was created on the Pinnacle
treatment planning system for each patient in this study. The vol-
umes of interest were manually segmented on the pCT image sets
for all cases, including gross tumor volume (GTV), internal target vol-
ume (ITV), clinical target volume (CTV) and planning target volume
(PTV). GTV included the gross tumor and involved nodes as defined
on the planning CT images; ITV was defined as the envelope that
encompassed the GTV plus the full range of tumor motion identified
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on the 4D CT. The CTV was generated by adding an addition 5 mm
margin, shaved off anatomic barriers to tumor spread, to the ITV.
The PTV was obtained by adding 5 mm margin to CTV in all direc-
tions. Organs at risk (OAR), including bilateral lungs, spinal cord,
esophagus, and heart were also delineated.
2.D | “Dose of the day” calculations based on rCT
and vCT
The initial treatment plan was performed with coplanar or non‐copla-
nar 6 MV photon beams on the pCT image sets. The treatment
beams from the initial plan were copied and applied to the isocen-
ters of the rCT and vCT for subsequent dosimetric study (denoted
as rCT dose and vCT dose, respectively) using the collapsed cone
algorithm in Pinnacle with a 3 × 3 × 3 mm3 dose grid (Fig. 1). Note
that all beam parameters including isocenter, control points, and
monitor units were kept identical to the initial treatment plan in this
dose recalculation step.
2.E | Dose accumulation
The vCT‐based accumulated dose was also performed with the
Demons DIR algorithm to warp the vCT dose distributions as well as
vCT to pCT image sets. It was presumed that the pCT plan was
delivered in the first 10 fractions, followed by delivery of the vCT
plan or rCT for the rest 20 fractions, therefore, accumulated dose
was achieved by summing 10 times of pCT dose with 20 times of
vCT or rCT dose. And rCT‐based accumulated dose performed by
the same approach was used as reference to access the accuracy of
vCT‐based accumulated dose. A set of DVH metrics was evaluated
in this study, including PTV‐D95% (minimum dose delivered to 95%
of the PTV), lung‐V20Gy (volume receiving at least 20Gy to the
lung), heart‐V45Gy (volume receiving at least 45Gy to the heart), the
maximum dose (Dmax) to the spinal cord, as well as the mean doses
(Dmean) to PTV, lung‐CTV and heart.
2.F | Statistical analysis
Bland‐Altman analysis was used for analyzing dosimetric difference
between vCT and rCT based accumulated dose for all DVH metrics.
The mean differences ± 1.96 times the standard deviation (SD) were
defined as the limit of agreement (LOA). Statistical analyses were
performed using GraphPad Prism software (v5.0, GraphPad Software,
LaJoIIA, USA).
3 | RESULTS
3.A | Example of the poor and good results
Figure 2 shows a case exhibiting poor agreement in dosimetric com-
parison and their corresponding images. There are dose discrepan-
cies between the vCT (dash line) and rCT (solid line) based
accumulated doses [Fig. 2(a)] for OAR including spinal cord, lung‐
CTV and esophagus. And the largest discrepancy was observed in
spinal cord in particular. In addition, isodose distribution comparisons
between vCT‐based [Fig. 2(b)] and rCT‐based accumulated dose
[Fig. 2(c)] are poorly correlated, particularly in the spinal cord region.
For this case, the CBCT of this patient has significant image quality
degradation and truncation due to large patient size [Fig. 2(d)], which
resulted in significant image distortion in vCT [Fig. 2(e)] and rCT
images [Fig. 2(f)].
In contrast, [Fig. 3(a)] shows a different case with good agree-
ment between vCT (dash line) and rCT (solid line) based accumulated
doses for the target volumes and OARs. The overall isodose distribu-
tion between vCT‐based [Fig. 3(b)] and rCT‐based accumulated
doses [Fig. 3(c)] were comparable. Superior CBCT image quality
([Fig. 3(d)]) led to small differences between vCT [Fig. 3(e)] and rCT
[Fig. 3(f)].
3.B | The comparison of accumulated dose for
target and OAR
Figure 4 and Table 1 show the Bland‐Altman plots and the LOA of
percentage difference between two accumulated doses based on
vCT and rCT. Considering the redundancy of the data, only a part of
DVH metrics including PTV (Dmean), Lung‐CTV (Dmean), spinal cord
(Dmax), esophagus (Dmean), and heart (Dmean), in evaluating lung plans
are shown in Fig. 4. The mean dose differences over 12 patients are
smaller than 1.5% for all evaluated metrics, except for the spinal
cord Dmax. As shown in Panel A, the mean difference for PTV Dmean
is −0.03%, with LOA between −1.59% and 1.53%. One outlier is
observed at −2.20%. The mean difference of Lung‐CTV Dmean is
−1.10%, with LOA at (−4.81%, 2.61%), as shown in Panel B. Spinal
cord Dmax exhibits a high mean difference of −5.55%, with LOA at
(−33.61%, 22.51%), as shown in Panel C, two subjects with
−49.74% (blue arrow) and −11.13% (red arrow) differences can also
F I G . 1 . The approach of “dose of the day” calculation based on
CBCT and DIR. CBCT, cone beam CT; DIR, deformable image
registration.
90 | YUAN ET AL.
be observed; discarding these high difference subjects, acceptable
mean differences at −0.57% and LOA at (−3.74%, 2.59%) for spinal
cord Dmax can be achieved. Panel D and E also show −0.8% and
−1.46% mean difference for esophagus Dmean and heart Dmean, with
a LOA at (−5.70%, 4.10%) and (−9.72%, 6.79%), respectively. Results
also show other outliers for esophagus Dmean and heart Dmean, with
(a) (b) (c)
(d) (e) (f)
F I G . 2 . A case exhibiting poor agreement between vCT (dash line) and rCT (solid line) based accumulated doses (a), and isodose distribution
comparison between vCT‐based accumulated dose (b) and rCT‐based accumulated dose (c), with their corresponding CBCT (d), vCT (e), and
rCT (f).CBCT, cone beam CT.
(a) (b) (c)
(d) (e) (f)
F I G . 3 . Another case exhibiting good agreement between vCT (dash line) and rCT (solid line) based accumulated doses (a), and isodose
distribution comparison between vCT‐based accumulated dose (b) and rCT‐based accumulated dose (c), with their corresponding CBCT (d), vCT
(e), and rCT (f). CBCT, cone beam CT.
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−6.46% and −10.30% differences, respectively, but with a good
agreement in comparison of absolute differences (not shown in the
paper).
It should be noted that the poor case shown in Fig. 2 also corre-
sponds to the red arrows in Fig. 4, which show large differences
with −11.13% [Fig. 4(c)] and −4.67% [Fig. 4(b)] in spinal cord Dmax
and lung‐CTV Dmean, respectively. Dose difference in esophagus
Dmean and heart Dmean are −3.03% and −3.69%, respectively (as
pointed out by red arrows in [Fig. 4(d)‐(e)]. While the good case
shown in Fig. 3 which indicated by the green arrows in Fig. 4, only
show less than 2% difference for all dosimetric parameters.
4 | DISCUSSION
The vCT image sets created in this study allows for accurate accumu-
lated dose calculation, comparable to the accumulated dose based on
the rCT. Results show less than 1.5% mean differences for most dose‐
volume metrics between the vCT and rCT based accumulated doses.
Mean dose difference (−5.55%) of spinal cord Dmax was observed in
two cases with poor CBCT image quality, which subsequently cause
large DIR errors between CT and CBCT images. The approach of
using the “dose of the day” calculation in this study was partly based
on the studies reported by Veiga et al.18,19 and Cole et al.,21 which
show less than 2% dose difference for head and neck patients,18,19
and close match for lung cancer patients21 when comparing vCT with
rCT doses. Furthermore, most studies on accumulated dose were
done evaluating DIR based accumulated dose from rCT (warping dose
from rCT to pCT）vs. initial plan dose.27,28 For example, Andersen
et al.27 found that deviations between DIR‐based dose accumulations
from rCT and the initial plan dose for prostate were substantial
(Range: −0.5 to 2.3 Gy for D2% and −9.4 to 13.5 Gy for Dmean),
whereas deviations between DIR‐based accumulations and DVH sum-
mation were small and well within 1 Gy. Tsudou et al.28 reported that
the dose to parotids for dose accumulation from rCT was higher than
the initial plan by 8.0% and 6.8% for ipsilateral and contralateral paro-
tids in head and neck patients. Veiga et al.25 also investigated accu-
mulated dose uncertainties using deformed images from pCT to
CBCT for head and neck patients. However, none have investigated
the accuracy of accumulated dose calculation based on vCT compared
to that of rCT. Results shown in this study demonstrated vCT has the
potential utility to provide a reasonable estimate for “dose of the day”
calculation.
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F I G . 4 . Bland‐Altman plots of percentage difference of the two accumulated dose (y‐axis) against mean accumulated dose (x‐axis), with mean
percentage difference (bias) (solid line) and the limits of agreement) (dash line) for PTV Dmean (a), Lung‐CTV Dmean (b), Spinal cord Dmax (c),
Esophagus Dmean (d), and Heart Dmean (e). CTV, clinical target volume; PTV, planning target volume.
TAB L E 1 The mean percentage differences and limits of agreement
of accumulated dosimetric parameters based on vCT and rCT.
Mean percentage
difference SD Limits of Agreement
PTV Dmean −0.03% 0.80% −1.59% to 1.53%
Lung‐CTV Dmean −1.10% 1.89% −4.81% to 2.61%
Spinal cord Dmax −5.55% 14.32% −33.61% to 22.51%
Esophagus Dmean −0.80% 2.50% −5.70% to 4.10%
Heart Dmean −1.46% 4.21% −9.72% to 6.79%
Abbreviations: CTV, clinical target volume; PTV, planning target volume;
SD, standard deviation.
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The Pinnacle’s Demons algorithm used in this study has been
validated by other groups for CT‐CBCT image deformation.29–31
Visual inspection was used for validating DIRs in this study. We
found from this study that the critical limiting factor to overall dose
accumulation accuracy is CBCT image quality, which would subse-
quently affect DIR results’ accuracy. As shown in the first example,
image truncation was observed in CBCT image [Fig. 2(d)] on the
right side of the patient body, thus large differences between vCT
vs. rCT [Figs. 2(e) and Fig. 2(f)] images. Poor CBCT image quality
caused by high scatter contamination due to large patient size and
projection truncation may propagate to less ideal DIR results. These
DIR errors may subsequently introduce high dose deviation in spinal
cord Dmax and lung‐CTV Dmean, as shown in [Fig. 4(c) and (b)] (red
arrows). In addition, it has been observed that vCT often associated
with greater truncation in the right chest wall region compared to
their corresponding original CBCT images, which may be attributed
to a chain of error propagation during the deformation process. High
image noise and low image contrast may be introduced to the simu-
lated CBCT images in the same region when deforming CBCT to
rCT, followed by mis‐registration errors introduced to the process of
deforming pCT to simulated CBCT, which therefore may lead to
higher truncation artifacts in vCT images. Note that image truncation
on vCT did not affect dose calculation since there were no beams
passing through the truncated regions. Another case with highest
difference for spinal cord Dmax (−49.74%, Fig. 4(c), blue arrow) is
also associated with poor CBCT image quality. Similar image artifacts
are observed in this case due to large patient size, truncation, and
inappropriate choices of imaging parameters (20mA tuber potential
and 20ms expose time).
Previous studies have shown that truncated artifacts, patient
size, and imaging parameters can affect CBCT image quality.32 Zhen
et al. pointed out that the missing information with truncated CBCT
images introduced incorrect deformation when a conventional DIR
algorithm is utilized, especially for intensity based algorithms.33
Meanwhile, low imaging parameters with large patient size may
result in more scatters. Wood et al.34 demonstrated that CBCT
image signal‐to‐noise ratio drops with increased phantom sizes.
Veiga et al.19 also pointed out large body size for CBCT imaging may
be the main source of error in recalculation proton dose on CBCT.
In contrast, small difference between vCT [Fig. 3(e) and rCT Fig. 3(f)]
can be observed for superior CBCT image (Fig. 3(D)). Dose differ-
ence of less than 2% can be observed for all evaluated metrics
(Fig. 4, green arrows), DVH and isodose distribution comparison
[Fig. 3(a)‐(c)]. In such a retrospective setting, we are limited to previ-
ously acquired images. We aim to improve our clinical protocol in
terms of CBCT scan setting in our future prospective studies.
Despite the promising results of the present study, there are
inherent limitations. First, due to the limited scanning range and
truncation in the CBCT, lung Dmean between vCT and rCT dose was
not evaluated without the whole lung contour. Second, considering
the slow gantry motion while acquiring CBCT image, to the study
may be improved if rCT was created as AveCT from 4D CT for the
comparison with CBCT. Third, statistical analysis cannot be achieved
in this study due to limited number of patients included. A follow‐up
study with large patient sample and standardized imaging parameters
is warranted to further identify uncertainties in using CBCT and DIR
for “dose of the day” calculation.
5 | CONCLUSION
The accuracy of “dose of the day” calculation based on vCT was
evaluated by comparing vCT with rCT based accumulated dosimetric
parameters. The vCT created in this study can be used to reasonably
estimate the “dose of the day” calculation for lung cancer patients
with mean difference smaller than 1.5% for most accumulated dose‐
volume metrics. The “dose of the day” also has the potential to
become a very useful tool for ART. Critical to this calculation
approach is CBCT image quality, which was found to be the main
contributing factor to less ideal vCT creation, and thus less accurate
dose accumulation.
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